Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Andrew D Barreto"'
Autor:
Mehmet Enes Inam, Elvira Lekka, Faheem G Sheriff, Aditya A Sanzgiri, Victor Lopez-Rivera, Andrew D Barreto, Sunil A Sheth, Carlos Artime, Allison C Engstrom, Alexander Ambrocik, Claudia Pedroza, Sean I Savitz, Peng Roc Chen
Publikováno v:
Brain Circulation, Vol 7, Iss 3, Pp 201-206 (2021)
INTRODUCTION: Prior retrospective and case-control studies have shown that the use of general anesthesia (GA) during endovascular therapy (EVT) for acute ischemic stroke with large vessel occlusion (AIS-LVO) was independently associated with poor cli
Externí odkaz:
https://doaj.org/article/445a0cf4ea42442b989c3350e1ac12e0
Autor:
Mehmet Enes Inam, Aditya Sanzgiri, Elvira Lekka, Sunil A Sheth, Andrew D Barreto, Sean I Savitz, Carlos Artime, Claudia Pedroza, Allison Engstrom, Faheem G Sheriff, Alexander Ambrocik, Peng Roc Chen
Publikováno v:
Brain Circulation, Vol 7, Iss 4, Pp 253-258 (2021)
INTRODUCTION: Patients with acute ischemic stroke (AIS) and neurologic deficits are often unable to provide consent and excluded from emergency research participation. Experiences with exception from informed consent (EFIC) to facilitate research on
Externí odkaz:
https://doaj.org/article/f23ab9e2c3f14c5a823b8e7dbf3a3617
Autor:
Andrei V. Alexandrov, Georgios Tsivgoulis, Martin Köhrmann, Aristeidis H. Katsanos, Lauri Soinne, Andrew D. Barreto, Travis Rothlisberger, Vijay K. Sharma, Robert Mikulik, Keith W. Muir, Christopher R. Levi, Carlos A. Molina, Maher Saqqur, Dimitris Mavridis, Theodora Psaltopoulou, Milan R. Vosko, Jochen B. Fiebach, Pitchaiah Mandava, Thomas A. Kent, Anne W. Alexandrov, Peter D. Schellinger
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: Results of our recently published phase III randomized clinical trial of ultrasound-enhanced thrombolysis (sonothrombolysis) using an operator-independent, high frequency ultrasound device revealed heterogeneity of patient recruitment amo
Externí odkaz:
https://doaj.org/article/46bc592950ae4562b12fc62907bd0d52
Autor:
Mahan Shahrivari, Vedang Vyas, Muhammad Bilal Tariq, Bronson Ciavarra, Abhijeet Dhoble, Andrew D Barreto, Anjail Z Sharrief
Publikováno v:
Stroke. 54
Background and Objective: Right to left shunts (RLS) found with patent foramen ovale (PFO) are implicated in the pathogenesis of cryptogenic stroke and a risk factor for neurological event. The capability and sensitivity of Transcranial Doppler ultra
Autor:
Joseph P. Broderick, Yasmin N. Aziz, Opeolu M. Adeoye, James C. Grotta, Andrew M. Naidech, Andrew D. Barreto, Colin P. Derdeyn, Heidi J. Sucharew, Jordan J. Elm, Pooja Khatri
Publikováno v:
Stroke.
Randomized clinical trials of acute stroke have led to major advances in acute stroke therapy over the past decade. Despite these successes, recruitment in acute trials is often difficult. We outline challenges in recruitment for acute stroke trials
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Despite the proven efficacy of intravenous alteplase or endovascular thrombectomy for the treatment of patients with acute ischemic stroke, only a minority receive these treatments. This low treatment rate is due in large part to delay in hospital ar
Externí odkaz:
https://doaj.org/article/28368093b9cd46e3bbcb3ea9ae619277
Autor:
Sean I. Savitz, Andrew D. Barreto
Publikováno v:
Frontiers in Stroke. 1
Autor:
Mark J Dannenbaum, Clark Sitton, Ameer E Hassan, Sheryl Martin-Schild, Bader Alenzi, Georgios Tsivgoulis, Andrew D Barreto, James C. Grotta, Rishi Gupta, Spiros Blackburn, Haris Kamal, Nirav Vora, Chunyan Cai, William J Hicks, Ronald F. Budzik, Amrou Sarraj, Ashish Arora, Gregory W. Albers, Osman Mir, Maarten G Lansberg, Arthur L. Day, Wondwossen G Tekle, Deep Pujara, Michael G. Abraham, Sean I Savitz
Publikováno v:
Neurology
ObjectiveTo evaluate the comparative safety and efficacy of direct endovascular thrombectomy (dEVT) compared to bridging therapy (BT; IV tissue plasminogen activator + EVT) and to assess whether BT potential benefit relates to stroke severity, size,
Publikováno v:
Seminars in Neurology. 41:016-027
Acute ischemic stroke (AIS) is a time sensitive medical emergency and a leading cause of morbidity and mortality worldwide. Intravenous (IV) recombinant tissue plasminogen activator (IV alteplase) is currently the only proven effective medication for
Autor:
Scott M. Berry, Scott Janis, Colin P. Derdeyn, S Iris Deeds, Andrew D Barreto, Joseph P. Broderick, Claudia S. Moy, James C. Grotta, Opeolu Adeoye, Jordan J. Elm, Pooja Khatri
Publikováno v:
Int J Stroke
Background Intravenous recombinant tissue plasminogen activator is the only proven effective medication for the treatment of acute ischemic stroke. Two approaches that may augment recombinant tissue plasminogen activator thrombolysis and prevent arte